Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Clinical trial NCT01134250 · COMPLETED

Trial details

NCT number: NCT01134250
Sponsor: Philogen S.p.A.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Breast Cancer Metastatic Melanoma Non-small Cell Lung Cancer (NSCLC)

Start date: 2008-08-06
Primary completion: 2014-04-07
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.